fda warning letter compounding semaglutide october 2025 Bad news: You may get cut off from your GLP-1 this week… FDA Issues Warnings Against Illegal
Description
Our physicians conduct thorough assessments before recommending any specific GLP-1 protocol, ensuring a personalised, precision medicine approach
Unfortunately, we are informed that this limited availability is likely to continue until mid-2024
In my lifetime, I have not seen anything revolutionize diabetes (and certainly obesity) care in the way GLP-1 receptor agonists have in the last few years
91 Diabetic mice also show astrocyte changes in the hippocampus
ArticlePubMed 44
